Sighencea M, Popescu R, Trifu S
Int J Mol Sci. 2024; 25(22).
PMID: 39596378
PMC: 11594972.
DOI: 10.3390/ijms252212311.
Leventhal M, Zanella C, Kang B, Peng J, Gritsch D, Liao Z
bioRxiv. 2024; .
PMID: 38559190
PMC: 10980014.
DOI: 10.1101/2024.03.17.585262.
Shukla M, Vincent B
Curr Neuropharmacol. 2023; 21(5):1273-1298.
PMID: 36918783
PMC: 10286584.
DOI: 10.2174/1570159X21666230314142505.
Beckmann A, Ramirez P, Gamez M, Gonzalez E, De Mange J, Bieniek K
iScience. 2023; 26(3):106152.
PMID: 36879821
PMC: 9984563.
DOI: 10.1016/j.isci.2023.106152.
Lapresa R, Agulla J, Bolanos J, Almeida A
Front Pharmacol. 2023; 13:1086540.
PMID: 36588673
PMC: 9794583.
DOI: 10.3389/fphar.2022.1086540.
E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging.
Ramon-Landreau M, Sanchez-Puelles C, Lopez-Sanchez N, Lozano-Urena A, Llabres-Mas A, Frade J
Int J Mol Sci. 2022; 23(20).
PMID: 36292945
PMC: 9603043.
DOI: 10.3390/ijms232012093.
Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons.
Guan P, Ding W, Wang P
Front Mol Neurosci. 2022; 15:1006216.
PMID: 36263378
PMC: 9575964.
DOI: 10.3389/fnmol.2022.1006216.
LncRNA RP11-59J16.2 aggravates apoptosis and increases tau phosphorylation by targeting MCM2 in AD.
Guan F, Gao Q, Dai X, Li L, Bao R, Gu J
Front Genet. 2022; 13:824495.
PMID: 36092938
PMC: 9459667.
DOI: 10.3389/fgene.2022.824495.
Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease.
Traxler L, Herdy J, Stefanoni D, Eichhorner S, Pelucchi S, Szucs A
Cell Metab. 2022; 34(9):1248-1263.e6.
PMID: 35987203
PMC: 9458870.
DOI: 10.1016/j.cmet.2022.07.014.
Model scenarios for cell cycle re-entry in Alzheimer's disease.
Pandey N, Vinod P
iScience. 2022; 25(7):104543.
PMID: 35747391
PMC: 9209725.
DOI: 10.1016/j.isci.2022.104543.
PROTACs technology for treatment of Alzheimer's disease: Advances and perspectives.
Inuzuka H, Liu J, Wei W, Rezaeian A
Acta Mater Med. 2022; 1(1):24-41.
PMID: 35237768
PMC: 8887676.
DOI: 10.15212/amm-2021-0001.
p53-mediated neurodegeneration in the absence of the nuclear protein Akirin2.
Peek S, Bosch P, Bahl E, Iverson B, Parida M, Bais P
iScience. 2022; 25(2):103814.
PMID: 35198879
PMC: 8844820.
DOI: 10.1016/j.isci.2022.103814.
E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer's Disease Mouse Model 5xFAD.
Lopez-Sanchez N, Garrido-Garcia A, Ramon-Landreau M, Cano-Daganzo V, Frade J
Neurotherapeutics. 2021; 18(4):2484-2503.
PMID: 34766258
PMC: 8804140.
DOI: 10.1007/s13311-021-01151-1.
The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago.
Snow A, Cummings J, Lake T
Front Aging Neurosci. 2021; 13:710683.
PMID: 34671250
PMC: 8521200.
DOI: 10.3389/fnagi.2021.710683.
Nuclear dynamics and stress responses in Alzheimer's disease.
Iatrou A, Clark E, Wang Y
Mol Neurodegener. 2021; 16(1):65.
PMID: 34535174
PMC: 8447732.
DOI: 10.1186/s13024-021-00489-6.
Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
Barrett T, Stangis K, Saito T, Saido T, Park K
J Alzheimers Dis. 2021; 82(4):1683-1702.
PMID: 34219712
PMC: 8461670.
DOI: 10.3233/JAD-210091.
Enduring glucocorticoid-evoked exacerbation of synaptic plasticity disruption in male rats modelling early Alzheimer's disease amyloidosis.
Qi Y, Klyubin I, Ondrejcak T, Hu N, Rowan M
Neuropsychopharmacology. 2021; 46(12):2170-2179.
PMID: 34188184
PMC: 8505492.
DOI: 10.1038/s41386-021-01056-9.
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.
Balmik A, Chinnathambi S
Cell Commun Signal. 2021; 19(1):51.
PMID: 33962636
PMC: 8103764.
DOI: 10.1186/s12964-021-00732-z.
Oligomer β-amyloid Induces Hyperactivation of Ras to Impede NMDA Receptor-Dependent Long-Term Potentiation in Hippocampal CA1 of Mice.
Wang Y, Shi Z, Zhang Y, Yan J, Yu W, Chen L
Front Pharmacol. 2021; 11:595360.
PMID: 33536910
PMC: 7848859.
DOI: 10.3389/fphar.2020.595360.
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer.
Papin S, Paganetti P
Brain Sci. 2020; 10(11).
PMID: 33207722
PMC: 7696480.
DOI: 10.3390/brainsci10110862.